Paul Nieberg

481 total citations
19 papers, 349 citations indexed

About

Paul Nieberg is a scholar working on Epidemiology, Infectious Diseases and Applied Microbiology and Biotechnology. According to data from OpenAlex, Paul Nieberg has authored 19 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 7 papers in Infectious Diseases and 7 papers in Applied Microbiology and Biotechnology. Recurrent topics in Paul Nieberg's work include Antibiotic Use and Resistance (7 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Antibiotic Resistance in Bacteria (6 papers). Paul Nieberg is often cited by papers focused on Antibiotic Use and Resistance (7 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Antibiotic Resistance in Bacteria (6 papers). Paul Nieberg collaborates with scholars based in United States. Paul Nieberg's co-authors include Annie Wong‐Beringer, Emi Minejima, Rosemary C. She, Wendy J. Mack, Mimi Lou, Melissa Mert, Brad Spellberg, Sarah C J Jorgensen, Mira Zurayk and Jason Yamaki and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Critical Care Medicine.

In The Last Decade

Paul Nieberg

18 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Nieberg United States 10 176 159 140 77 57 19 349
Roni Bitterman Israel 11 186 1.1× 106 0.7× 57 0.4× 33 0.4× 83 1.5× 27 475
V. S. Randhawa India 11 139 0.8× 101 0.6× 54 0.4× 129 1.7× 57 1.0× 20 332
Oriol Gasch Spain 13 180 1.0× 293 1.8× 184 1.3× 95 1.2× 42 0.7× 39 446
Aline El Zakhem Lebanon 12 218 1.2× 191 1.2× 46 0.3× 45 0.6× 28 0.5× 30 424
A Moreno-Martínez Spain 6 218 1.2× 215 1.4× 185 1.3× 83 1.1× 33 0.6× 9 368
Andrew A. Mahony Australia 10 148 0.8× 151 0.9× 73 0.5× 40 0.5× 56 1.0× 20 339
R. Brigg Turner United States 11 94 0.5× 167 1.1× 94 0.7× 31 0.4× 24 0.4× 16 323
Merel M. C. Lambregts Netherlands 10 151 0.9× 68 0.4× 98 0.7× 44 0.6× 28 0.5× 28 307
SHARON NABERHUIS-STEHOUWER United States 8 147 0.8× 400 2.5× 239 1.7× 177 2.3× 57 1.0× 8 528
Jacqueleen Wise United States 7 203 1.2× 56 0.4× 115 0.8× 59 0.8× 146 2.6× 10 399

Countries citing papers authored by Paul Nieberg

Since Specialization
Citations

This map shows the geographic impact of Paul Nieberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Nieberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Nieberg more than expected).

Fields of papers citing papers by Paul Nieberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Nieberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Nieberg. The network helps show where Paul Nieberg may publish in the future.

Co-authorship network of co-authors of Paul Nieberg

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Nieberg. A scholar is included among the top collaborators of Paul Nieberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Nieberg. Paul Nieberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Nieberg, Paul, et al.. (2025). Carbapenem de-escalation as an antimicrobial stewardship strategy: a narrative review. JAC-Antimicrobial Resistance. 7(2). dlaf022–dlaf022. 1 indexed citations
2.
3.
4.
Lou, Mimi, et al.. (2022). Unvaccinated Non-Elderly Adult Population Hospitalized for COVID-19: Risk for Severe Disease and Poor Outcomes. Journal of Primary Care & Community Health. 13. 4267739298–4267739298.
5.
Le, Diana, Mimi Lou, Emi Minejima, et al.. (2022). Temporal Dynamics of Host Immune Response Associated With Disease Severity and Time to Recovery in Patients Hospitalized for COVID-19. Critical Care Explorations. 4(9). e0760–e0760. 3 indexed citations
6.
Minejima, Emi, et al.. (2021). Cytokine measurements add value to clinical variables in predicting outcomes for Staphylococcus aureus bacteremia. BMC Infectious Diseases. 21(1). 317–317. 10 indexed citations
7.
Nieberg, Paul, et al.. (2021). Risk factors and outcome associated with infection or colonization due to carbapenem-heteroresistant Escherichia coli. JAC-Antimicrobial Resistance. 3(1). dlab036–dlab036. 3 indexed citations
8.
Lou, Mimi, et al.. (2021). Factors associated with prompt recovery among hospitalised patients with coronavirus disease 2019. International Journal of Clinical Practice. 75(11). e14818–e14818. 4 indexed citations
9.
Nguyen, Kevin, et al.. (2020). Prevalence of the carbapenem-heteroresistant phenotype among ESBL-producing Escherichia coli and Klebsiella pneumoniae clinical isolates. Journal of Antimicrobial Chemotherapy. 75(6). 1506–1512. 17 indexed citations
10.
Minejima, Emi, Melissa Mert, Wendy J. Mack, et al.. (2019). Defining the Breakpoint Duration of Staphylococcus aureus Bacteremia Predictive of Poor Outcomes. Clinical Infectious Diseases. 70(4). 566–573. 97 indexed citations
11.
Minejima, Emi, et al.. (2019). Utility of qSOFA score in identifying patients at risk for poor outcome in Staphylococcus aureus bacteremia. BMC Infectious Diseases. 19(1). 149–149. 14 indexed citations
12.
Ozaki, Aya, et al.. (2019). Antimicrobial Stewardship Opportunities in Patients with Bacteremia Not Identified by BioFire FilmArray. Journal of Clinical Microbiology. 57(5). 9 indexed citations
13.
Jorgensen, Sarah C J, et al.. (2018). Leveraging Antimicrobial Stewardship in the Emergency Department to Improve the Quality of Urinary Tract Infection Management and Outcomes. Open Forum Infectious Diseases. 5(6). ofy101–ofy101. 23 indexed citations
14.
Jorgensen, Sarah C J, et al.. (2017). Risk factors for early return visits to the emergency department in patients with urinary tract infection. The American Journal of Emergency Medicine. 36(1). 12–17. 37 indexed citations
15.
Jorgensen, Sarah C J, et al.. (2017). Emergency Department Urinary Antibiograms Differ by Specific Patient Group. Journal of Clinical Microbiology. 55(9). 2629–2636. 20 indexed citations
16.
Minejima, Emi, Joanna S. Wu, Joshua Wang, et al.. (2017). Staphylococcus aureus Bacteremia in Patients not Meeting Sepsis Criteria: Clinical Features, Host Immune Response and Outcomes.. PubMed. 2(4). 6 indexed citations
17.
Minejima, Emi, Rosemary C. She, Wendy J. Mack, et al.. (2015). A Dysregulated Balance of Proinflammatory and Anti-Inflammatory Host Cytokine Response Early During Therapy Predicts Persistence and Mortality in Staphylococcus aureus Bacteremia*. Critical Care Medicine. 44(4). 671–679. 53 indexed citations
18.
Nieberg, Paul, et al.. (2015). Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections. American Journal of Infection Control. 43(10). 1076–1080. 17 indexed citations
19.
Minejima, Emi, Mimi Lou, Paul Nieberg, & Annie Wong‐Beringer. (2014). Patients presenting to the hospital with MRSA pneumonia: differentiating characteristics and outcomes with empiric treatment. BMC Infectious Diseases. 14(1). 252–252. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roni Bitterman Breakdown of academic impact, for papers by V. S. Randhawa Breakdown of academic impact, for papers by Oriol Gasch Breakdown of academic impact, for papers by Aline El Zakhem Breakdown of academic impact, for papers by A Moreno-Martínez Breakdown of academic impact, for papers by Andrew A. Mahony Breakdown of academic impact, for papers by R. Brigg Turner Breakdown of academic impact, for papers by Merel M. C. Lambregts Breakdown of academic impact, for papers by SHARON NABERHUIS-STEHOUWER Breakdown of academic impact, for papers by Jacqueleen Wise
Rankless by CCL
2026